+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus

Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus

Fetal and Pediatric Pathology 23(4): 241-249

Tuberous sclerosis complex (TSC) is a common autosomal dominant disorder in which affected patients develop a wide variety of benign and malignant tumors. We report here on a 31-week gestational age fetus with pathological features of TSC. Developmental expression of hamartin and tuberin in various tissues was studied using immunohistochemistry. There was loss of expression of hamartin in the tuber and weak expression of the tuberin. Both hamartin and tuberin were expressed in bronchial epithelial cells, cardiac muscles, renal collecting tubules, and neural tissues. The rhabdomyomas stained negatively for tuberin and hamartin. Two genetic loci are responsible for TSC-TSCI and TSC2. The TSC1 gene on chromosome 9 encodes a protein termed hamartin that lacks sequence similarity to any known proteins, whereas the TSC2 gene on chromosome 16 codes for a protein termed tuberin. These results indicate that tuberin and hamartin may play a critical role in development and thus provide a framework for understanding the developmental and hamartomatous manifestations of tuberous sclerosis.

(PDF emailed within 1 workday: $29.90)

Accession: 050863269

Download citation: RISBibTeXText

PMID: 16095035

Related references

Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin. Pediatric and Developmental Pathology 5(5): 448-464, 2002

Developmental expression of the tuberous sclerosis proteins tuberin and hamartin. Acta Neuropathologica 101(3): 202-210, 2001

Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas. Journal of Cutaneous Pathology 30(3): 174-177, 2003

Expression of the tuberous sclerosis complex gene products, hamartin and tuberin, in central nervous system tissues. Acta Neuropathologica 99(3): 223-230, 2000

Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type. Folia Neuropathologica 46(1): 43-48, 2008

A case of intractable epilepsy: diagnosis of tuberous sclerosis based on histopathological findings and immunohistochemical expression of hamartin and tuberin. No to Hattatsu. Brain and Development 34(1): 49-54, 2002

Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis. Journal of Child Neurology 19(2): 102-106, 2004

Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms. Pathology, Research and Practice 212(11): 972-979, 2016

Multicompartmental distribution of the tuberous sclerosis gene products, hamartin and tuberin. Archives of Biochemistry & Biophysics 404(2): 210-217, August 15, 2002

Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis. Acta Neuropathologica 99(5): 503-510, 2000

Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis. Journal of Biological Chemistry 276(24): 21017-21021, 2001

Cellular co-localization of hamartin and tuberin and early hamartoma formation in tuberous sclerosis. Laboratory Investigation 82(1): 314A, 2002

The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene 19(54): 6306-6316, 2000

Definition of domains mediating interaction between hamartin and tuberin and disruption by tuberous sclerosis associated mutations. Journal of Medical Genetics 37(Supplement 1): S23, 2000

Hamartin, the product of the tuberous sclerosis 1 gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Research 58(21): 4766-4770, Nov 1, 1998